NUTLIN-3

NUTLIN-3 has been studied in 2 papers since 2021: none in people yet, 1 in cells, 1 review. No study of it in people or animals has been published yet. The newest paper, May 5, 2025: “ATM and p53 in aging and cancer: a double-edged sword in genomic integrity”.

Intervention

2 papers study it2 more mention it2 findingsUpdated

PubChemChEBIMeSH

See all 4 papers on NUTLIN-3

At a glance

The findings reach cells, none yet in people. 1 lab in 1 country.

None of its findings points the other way.

Cells: a single group. Worms or flies, mice and humans: nothing yet.
  • 1 lab in 1 country
  • Funders: National Cancer Institute and 2 more
  • Cells1

What did studies of NUTLIN-3 find?

2

Studies of NUTLIN-3 measured 2 outcomes: notch signaling and asymmetric stem cell self-renewal.

Notch signaling

upin human cells1

1 study
  1. NUTLIN-3 increases notch signaling in human cells (keratinocytes).

    “Nutlin-3 increased Notch signaling (NICD, Hes1)”

    Cellskeratinocytesepidermis

    Decreased p53 is associated with a decline in asymmetric stem cell self-renewal in aged human epidermis

    Aging cell

More on Notch signaling

Asymmetric stem cell self-renewal

upin human cells1

1 study
  1. NUTLIN-3 increases asymmetric stem cell self-renewal in human cells (aged keratinocytes) (returned to adult levels).

    “Nutlin-3 (a p53 activator) returned p53 activity as well as asymmetric SC self-renewal divisions to adult levels.”

    Cellsaged keratinocytesepidermis

    Decreased p53 is associated with a decline in asymmetric stem cell self-renewal in aged human epidermis

    Aging cell

Latest